<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24099927</identifier>
<setSpec>1695-9531</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pérez-Cerdá, C</dc:author>
<dc:author>González, I</dc:author>
<dc:author>Dalmau, J</dc:author>
<dc:author>Vitoria, I</dc:author>
<dc:author>Rausell, D</dc:author>
<dc:description xml:lang="en">We report a case of holocarboxylase synthetase deficiency with normal pyruvate carboxylase activity in the lymphocytes of an 8 year-old girl with clinical toxicity without the classic dermatological involvement. The identification of three nucleotide changes in the holocarboxylase synthetase (HLCS) gene, only one of them described as a pathogenic mutation could be related to a slight variant of the disease that would explain the unusual presentation beyond the age of infant. Treatment with biotin at 40 mg/day with protein controlled diet allows normal physical growth and psychomotor development for their age.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:subject>Deficiencia múltiple de carboxilasas</dc:subject>
<dc:subject>Holocarboxilasa sintetasa</dc:subject>
<dc:subject>Holocarboxylase synthetase</dc:subject>
<dc:subject>Multiple carboxylase deficiency</dc:subject>
<dc:subject>Biotin</dc:subject>
<dc:subject>Biotina</dc:subject>
<dc:date>2014 Mar </dc:date>
<dc:title xml:lang="es">Deficiencia de holocarboxilasa sintetasa de presentación tardía con actividad piruvato carboxilasa normal.</dc:title>
<dc:title xml:lang="en">[Delayed onset holocarboxylase synthetase deficiency with normal pyruvate carboxylase activity].</dc:title>
<dc:publisher>Anales de pediatria (Barcelona, Spain : 2003)</dc:publisher>
</metadata>
</record>
</pubmed-document>
